Showing results (11-20 of 122) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 1, 1994
Schedule-dependent topoisomerase II-inhibiting drugsS P Joel, M L SlevinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancerM L Slevin, P I Clark, S P Joel, et al.European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Cancer information: a cost-effective interventionJ Mossman, M Boudioni, M L SlevinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicityP I Clark, M L Slevin, S P Joel, et al.Drugs|March 11, 2000
Current role of oral etoposide in the management of small cell lung cancerP I ClarkSeminars in Oncology|April 1, 1992
Clinical pharmacology and schedule dependency of the podophyllotoxin derivativesP I ClarkCardiology Clinics|August 1, 1984
Physiologic signs and symptoms: contribution to the interpretation of the exercise testP I ClarkCardiology Clinics|August 1, 1984
Arrhythmias and conduction disturbances: impact on exercise testingP I ClarkCancer Chemotherapy and Pharmacology|January 1, 1994
Etoposide dosage and pharmacodynamicsS P Joel, R Shah, M L SlevinCytokine|November 1, 1990
Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humansM Lantz, S Malik, M L Slevin, et al.Pageof 13